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Abstract 
As the second leading cause of cancer-related deaths in the United States, colon 
cancer has a high cure rate if detected early by a colonoscopy (U.S. Cancer Statistics 
Working Group, 2007).  However, more than 41 million at-risk Americans are not 
properly receiving colonoscopy screenings according to the recommendations of the 
Center for Disease Control.  This study provides insight into the physiological and 
psychological benefits of the colonoscopy procedure over and above cancer detection 
and prevention.  Thirty-six patients receiving colonoscopic screening at the 
University of Connecticut Health Center participated in this study.  A questionnaire 
battery that assessed perceived stress, depressive symptoms, colon cancer related 
worry, and social support, and optional saliva sampling was completed 2 weeks 
prior to and post colonoscopy. It was hypothesized that salivary cortisol 
concentrations, perceived stress, and self-reported depressive symptoms would 
show significant decreases from pre to post colonoscopy, and that these variables 
would all be positively correlated with one another. Results showed significant, 
positive correlations between depressive symptoms and both salivary cortisol (r 
(34)= .348, p< .05) and perceived stress (r (34)= .635, p< .01).  Morning salivary 
cortisol levels decreased significantly from pre to post colonoscopy to levels below 
the population mean (t (16)=-3.711, p<. 01).  No such differences were observed in 
either perceived stress or depressive symptoms.  These results indicate that by 
decreasing cortisol concentrations to levels below that of the population mean, the 
colonoscopy provided physiological health benefits to patients beyond cancer 
screening. From a health psychology standpoint, this may encourage some of the 41 
million Americans not receiving proper colon cancer screenings to adopt this 
potentially life-saving health behavior. 
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Salivary cortisol and psychological stress in patients undergoing colon cancer 
screenings 
 
Maladaptive psychological factors have been shown to negatively impact 
physical health, affecting the morbidity and mortality rates across numerous 
medical conditions.  Some of these include cardiovascular disease, hypertension, 
diabetes, asthma, irritable bowel syndrome, and migraines (Roy et al., 2001; 
Bradley, 1988; Mrazek & Klinnert, 1996).  Chronic stress and depression tend to 
exacerbate physiological problems in healthy individuals, those at risk for 
developing disease, and current clinical populations seeking treatments.  Central to 
this study, levels of stress and depressive symptomatology are also particularly 
related to cancer biomarkers, and may impact the morbidity and mortality of certain 
cancers, as well (Andersen et al., 1998; Bhagwagar et al., 2003).    Much of the 
literature available in this area focuses primarily on patients already diagnosed with 
breast or prostate cancer, leaving room for inquiries regarding cancer prevention 
and screening.  This study aims to investigate elements of both psychological and 
physical health within the context of an at-risk population undergoing colon cancer 
screenings.  
Psychological Stress, Depression, and Cancer 
 Undoubtedly, the diagnosis and treatment of cancer is an inherently stressful 
experience for both patients and family members.  The perception of psychological 
distress is common in individual case reports of cancer patients, and has been 
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observed in empirical studies as well (Sivesind & Baile, 2001).  In rare cases, the 
patient’s experience with cancer can precipitate the development of post-traumatic 
stress symptoms as a reaction to mounting stress (Cordova & Andrykowski, 2003).  
Accordingly, depressive symptoms are also commonly reported in patients suffering 
from nearly all forms of cancer (Massie, 2004).  And while it is of interest to observe 
the effects of these maladaptive psychological functions in patients already 
diagnosed with cancers, the degree to which these variables contribute to diagnosis 
is also worth of exploration.  In a study of women at-risk for developing breast 
cancer, those reporting greater levels of depressive symptoms and stress in daily life 
were found to have a 4-fold increased risk for developing breast cancer over those 
who did not share such a degree of mood alteration and daily stressful experiences 
(Kruk & Aboul-Enein, 2004).   
While it is known that psychological factors such as stress and depression 
adversely affect the quality of life and daily functioning of cancer patients (Tsunoda 
et al., 2005), they have also been shown to negatively impact physiological processes 
leading to ill health.  Reductions in immune system functioning were observed in 
breast cancer patients reporting higher levels of stress and depressive symptoms.  
Tumor surveillance mechanisms were disrupted, contributing to unchecked disease 
progression (Levy et al., 1987; Andersen et al, 1998).  Another study linked 
psychological stress to increased colon cancer mortality rates (Kojima et al., 2005).  
In the realm of cancer detection, one study documented an association between 
psychological stress and physiological risk factors in patients receiving prostate 
cancer screenings.  The men reporting higher degrees of psychological stress were 
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also found to have greater levels of prostate specific antigen, a marker present in 
large quantities in those with prostate cancer (Cohen et al, 2003; Stone et al, 1999).  
The same study also found that prostate cancer-specific worry was significantly 
associated with abnormal prostate antigen levels (Stone et al, 1999).     
While cancer-specific worry may feed psychological stress, social support 
resources may buffer adverse affects.  In a study conducted on cancer patients 
grouped by level of cancer-related worry, it was found that women and those with 
poor social support resources were more likely to have high levels of cancer-specific 
worry (Stefaneck et al., 1989).  Social support networks have been associated with 
higher rates of elderly African-American women receiving mammography and occult 
stool examinations in the context of cancer prevention (Kang & Bloom, 1993).  Thus, 
it appears that social support not only buffers stress when dealing with cancer 
diagnosis, but also contributes to better health behaviors by encouraging screening 
procedures.     
Cortisol and Cancer 
 Cortisol is the primary glucocorticoid stress hormone secreted from the 
adrenal cortex.  Part of the hypothalamic pituitary adrenal (HPA) axis, cortisol 
demonstrates a predictable diurnal pattern.  Serum levels are highest approximately 
30-60 minutes upon waking, and decrease over the course of the day, with the 
lowest serum concentration achieved after 3-5 hours into sleep (Stone et al., 2001).  
This normal diurnal pattern is driven by the amount of light transmitted through 
the retina to the hypothalamus (Weyerbrock et al., 1996).  In stressful situations, 
however, cortisol levels elevate quickly to aid in returning the body to homeostasis.  
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Serum levels are highly correlated with salivary levels, as it represents unbound, 
and biologically available levels of cortisol (Kirschbaum & Hellhammer, 1994), and is 
much easier to access for research studies.  Elevated salivary cortisol is found in 
patients experiencing depressive states and well as stressful conditions (Bhagwagar 
et al., 2003).  Thus, it is a reliable bio-indicator of individuals’ responses to stressful 
conditions and depression. 
 The disruption of proper cortisol levels is a well-documented phenomenon 
observed in breast cancer patients.  Persistent elevations, erratic peaks and troughs, 
as well as stagnant concentrations have all been observed in cancer patient 
populations (Akbulut et al, 1999; Haus et al, 2001; Touitou et al., 1996; Pompe et al., 
1996).  It is likely that elevation and erratic patterns are the results of increased 
stress levels, depression and related states of distress (Vedhara et al., 2006; 
Dettenborn et al., 2005; Bower et al., 2005; Giese-Davis et al., 2004).  Stagnant 
patterns, in which cortisol levels do not fluctuate throughout the day, may represent 
individuals experiencing a burnout of the HPA axis.  Seen in individuals 
experiencing chronically high levels of stress, the HPA axis may become overworked 
and fail to function properly (Pruessner et al., 1999).  Studies examining cortisol 
levels in patients with colon cancer demonstrated disruptions similar, though lesser 
in magnitude, to those observed in breast cancer patients (Mussi et al., 2003; Crippa 
et al, 2003; Mromon et al., 2002).  Though important findings, these studies focused 
on patients with metastatic colon cancer, and may not properly represent the entire 
population of colon cancer patients.  The only branch of inquiry into the relationship 
of psychological and physiological factors specifically related to colon cancer found 
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that music therapy during colonoscopy resulted in decreased salivary cortisol levels, 
presumably through reductions in stress (Uedo et al., 2004).   
 Disruption of cortisol concentration is not only problematic for responses to 
stressors, but may also affect cancer mortality rates.  Metastatic breast cancer 
patients subjected to disruption of cortisol concentration for 3 consecutive days 
showed increased mortality rates up to 7 years after completion of the study 
(Sephton et al., 2000).  Thus, disruption of the diurnal cortisol pattern was 
predictive of survival time in these patients.  Although the disruptions of cortisol 
seen in cancer patients may affect morbidity and mortality rates, little is known of 
the potential mechanisms underlying this association.  Perhaps heightened levels of 
stress and depression cause alterations in HPA axis functioning, as evidenced by 
abnormal cortisol levels.  This may impair the functioning of the immune system, 
contributing to the development and progression of cancer (Spiegel & Giese-Davis, 
2003).   
Colon Cancer 
To expand the breadth of knowledge in this field, this study focuses on 
individuals undergoing routine cancer screenings for colon cancer.  As the second 
leading cause of cancer-related deaths in the United States, 53,000 individuals died 
from colon cancer in 2004 alone (U.S. Cancer Statistics Working Group, 2007).  Men 
and women are equally susceptible, though men are slightly more likely to be 
diagnosed with colon cancer than women.  Across racial and ethnic groups, African-
Americans demonstrate increased incidence and mortality rates of colon cancer, as 
compared to Caucasians and Latinos (American Cancer Society, 2005).  The primary 
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risk factor is advancing age, with approximately 90% of cases occurring in people 
aged 50 and over.  Major physiological risk factors include inflammatory bowel 
disease, and a family history of colorectal cancer or polyps.  Lifestyle choices, such 
as lack of regular physical activity, low fruit and vegetable intake, a low fiber-high 
fat diet, alcohol and tobacco consumption, and being overweight or obese also 
contribute to increased overall risk of developing colon cancer (National Institute of 
Health, Prevention, 2008).  While some of these risk factors are inevitable, namely 
age and family history, many of the lifestyle choices are unfortunately common in 
today’s society.  Despite the fact that colon cancer is a significant health threat for 
many Americans, it is easily screened for and curable if caught at an early stage 
(National Institute of Health, Treatment, 2008).   
Colonoscopy, the most widely used colon cancer screening procedure, 
involves the insertion of a fiber-optic camera through the anal opening to view the 
rectum and most distal portions of the large intestine (National Institute of Health, 
Prevention, 2008).  If suspicious abnormal growths, known as polyps, are discovered 
in the patient’s intestine, the physicians can surgically remove them at the time of 
the colonoscopy.  Polyps removed and sent for biopsy may be completely benign, 
pre-cancerous growths, or actual colon cancer tumors.  According to the American 
Academy of Family Physicians, in the case of pre-cancerous growths and stage 1 
cancerous tumors, surgical removal is oftentimes sufficient to cure the condition.  
Despite the obvious necessity of colon cancer screenings, a colonoscopy is not the 
most comfortable of situations for patients, especially the preparation required prior 
to the procedure.  The colon must be completely cleared for the physician to get an 
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accurate view of the intestinal wall, requiring the use of strong laxatives and 
prohibiting the ingestion of anything other than clear liquids in the 24-48 hours 
prior to the procedure (National Institute of Health, Treatment, 2008).  This may be 
a factor deterring the 41.8 million Americans aged 50 and over not currently 
receiving adequate colonoscopic screenings according to the Center for Disease 
Control guidelines from adopting this potentially life-saving health behavior  (U.S. 
Cancer Statistics Working Group, 2007).   
Rationale and Hypotheses 
 To date, no study has examined the association between cortisol level and the 
psychological factors of stress and depression within the context of colon cancer 
prevention.  The study aimed to answer the following question: Is the act of 
receiving a colonoscopy, irrespective of the outcome of the test, affecting 
psychological and other markers of physical health?  Specifically, the variables of 
interest in this study were salivary cortisol levels, depressive symptoms, perceived 
stress, colon cancer-related worry, and social support.  It was hypothesized that 
higher levels of both perceived stress and depressive symptoms would be positively 
correlated with salivary cortisol levels.  This expectation is in accordance with the 
body of literature associating these variables.  As an individual experiences either a 
stressful or depressive state, the HPA axis compensates by releasing more cortisol 
into the body system (Stone et al., 1999; Kirschbaum & Hellhamer, 1994).  It was 
also hypothesized that salivary cortisol concentration, perceived stress, and 
depressive symptoms would all show significant decreases from pre- to post-
colonoscopy.  This result seems likely if the participants found the colonoscopy to be 
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a stressful event.  In such a case, the resolution of this stressor should allow for 
decreases in both the psychological faculties and the stress biomarker.  
 No expectations were specifically made regarding colon cancer-related worry 
because of the novelty of the assessment scale used in this study.  From previous 
research, it appears likely that cancer-related worry would be correlated with 
perceived stress, depressive symptoms and salivary cortisol levels, if the 
colonoscopy were viewed as a major stressor.  However, the newness of the 
measure limits the basis from which to draw hypotheses.  General findings and 
trends were investigated and discussed for possible implications.  Social support 
was included as a mitigating factor to buffer those suffering from high levels of 
stress and depressive symptoms from the physiological manifestation of stress.              
 
 
Method 
Participants 
 Thirty-six patients scheduled to receive colonoscopic cancer screenings as 
part of the Colon Cancer Prevention Program at the University of Connecticut 
Health Center (UCHC) were recruited for participation in this study.  For inclusion, 
participants were necessarily aged 50 and over with either a family history of 
colorectal cancer and/or heightened personal risk resulting from other known risk 
factors.   At time 1, the sample consisted of 36 participants (19 females and 17 
males).  At time 2, the sample dropped a considerable number to a total of 12 
participants (6 females and 6 males).   The attrition rate was not due to any 
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experimental condition or characteristic of the particular population.  During 
recruitment, there was a misunderstanding regarding the specific timeline of the 
study, leaving participants unaware of the follow-up scheduled for time 2.  Though 
this decreased the number of returning participants, the problem was realized 
quickly and rectified.  Following this, recruitment proceeded well, with many 
patients fully completing all portions of the study.         
Materials 
 Psychometric Measures.  The questionnaire battery consisted of 4 
psychological measures designed to assess perceived stress, self-report depressive 
symptoms, colon cancer-related worry, and social support.  The Perceived Stress 
Scale, PSS, (Cohen, Kamarck, & Mermelstein, 1983), a 14-item self-report Likert 
scale, was administered to measure the impact of daily stressors on personal 
functioning within the previous month.  Higher scores on this scale indicated a 
higher perception of stress in daily life.  This scale was of particular relevance to 
this study as it includes questions assessing the participant’s perceived level of 
control over daily life stressors.  The feeling of personal loss of control is an integral 
component of perception and manifestation of stress, especially within the realm of 
medical populations (Mineka & Kelly, 1989).  Through the use of this measure, 
psychological stress was assessed.  The Center for Epidemiologic Studies Depression 
Scale (CES-D) is a 20-item self-report scale that measures acute psychological 
distress and depressive symptomatology.  Since this measure assesses depressive 
thoughts and feelings only over the previous week, it more accurately measures 
dysphoria, unpleasantness and discomfort in mood, and not major clinical 
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depression (Radloff, 1977).  As with the PSS, higher scores on the CES-D indicate the 
presence of more depressive symptoms.   
The Colon Cancer Worry scale is an unpublished measure created by Dean 
Cruess, Ph.D. at the University of Connecticut to assess the colon cancer-specific 
thoughts and worries regarding potential colorectal cancer diagnosis (Appendix).  
This measure was included as a means for obtaining insight into the enduring 
emotional and cognitive events surrounding fear of diagnosis.  Using a 4-pont Likert 
scale, positive scores on this measure indicate increasing amounts of active 
worrying and intrusive fear of colorectal cancer diagnosis.  The final psychometric 
measure included in the questionnaire battery was the Interpersonal Support 
Evaluation List (Cohen & Hoberman, 1983), a 12-item self report measure assessing 
the participant’s perception of the availability of social support resources across 3 
major subtypes- appraisal, belonging, and tangible support.  This measure was 
included in the battery to act as a moderator for those experiencing high levels of 
perceived stress, depressive symptoms and cancer-related worry.  Those 
participants receiving high scores on this measure were considered to have ample 
social support to buffer the effects of challenges.     
Salivary Sampling.  To properly obtain and store participants’ saliva samples, 
143 2.0mL cryovials were purchased from Salimetrics, Inc., a leading laboratory 
supply company specializing in saliva collection and analysis.  Two Extended Range 
High-Sensitivity Salivary Cortisol Enzyme Immunoassay Kits were also obtained 
from Salimetrics, Inc., allowing for the saliva samples to be assayed directly in the 
laboratory of Dr. Dan Rosenberg at UCHC where the samples were housed at -80˚C.   
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Dr. Rosenberg’s laboratory also provided the laboratory equipment necessary for the 
completion of this assay (Salimetrics, Inc., 2006).   
Design and Procedure 
 This study was conducted at 2 time points scheduled approximately 1 month 
apart, with the colonoscopy procedure bisecting the study timeline equally, with 
time 1 and 2 occurring 2 weeks pre and post colonoscopy, respectively (Figure 1).  At 
both time points, participants were instructed to complete the 10-minute 
questionnaire battery in their own homes.   Additionally, optional saliva sampling 
was conducted on the morning of the same day to obtain cortisol concentrations and 
self-report data that displayed a high degree of temporal correspondence.  Saliva 
collection was completed according to instructions given to the participants from 
Salimetrics, Inc (Salimetrics, Inc, 2006).  Participants were asked to drool down the 
length of shortened plastic drinking straw into the cryovial until full.  Certain 
restrictions were necessarily placed on the participants to ensure accurate cortisol 
levels in the saliva samples.  Prior to collection participants were asked not to eat or 
drink for 1 hour, to abstain from alcohol consumption for 24 hours, and to avoid 
brushing their teeth for 2 hours, as these behaviors lead to alterations in baseline 
cortisol concentrations.  Saliva sampling was conducted according to two optional 
timelines, either AM/PM sampling or morning rise.  In the AM/PM method, a saliva 
sample was collected 1 hour upon awakening and 1 hour prior to bedtime.  Though 
this schedule is easier for participants to complete, a more accurate measure of 
cortisol concentration is achieved using the morning rise timeline.  For this method, 
5 saliva samples were taken at 15 minute intervals over the first hour of awakening 
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at 0, 15, 30, 45, and 60 minutes.   Regardless of the timeline of sampling, 
participants were instructed to freeze their samples in their home freezer and bring 
them in to their next appointment at UCHC.    
Data Analysis 
 Psychometric Data.  Questionnaire data was scored and entered into the 
computer for analysis by SPSS software.  A correlation matrix was created 
comparing the total scores of the PSS, CES-D, Colon Cancer Worry scale, and the 
ISEL-12 both pre and post colonoscopy.  Paired samples t-tests were also conducted 
on these totals to demonstrate whether significant changes occurred in these 
variables from pre- to post-colonoscopy.   
 Salivary Analysis.  All 143 saliva samples were assayed for cortisol 
concentration at UCHC according to the protocol of the Salimetrics Extended Range 
High-Sensitivity Salivary Cortisol Enzyme Immunoassay Kit (Salimetrics, Inc.).  The 
kits came preloaded with a standard amount of anti-cortisol monoclonal antibody in 
each well of the microtiter plate.  When the samples were added, the cortisol 
present in the sample bound to the antibody, rendering the antibody unable to 
further complex with other available cortisol molecules.  A standard, enzyme-linked 
cortisol was then added to bind the remaining available anti-cortisol antibodies.  
When the substrate for the enzyme was added to each well, a characteristic color 
change was produced.  Measuring the amount of light transmitted through each 
individual well using a plate reader, the amount of enzyme-linked cortisol was 
determined.   The inverse of this corresponded with the amount of cortisol present 
in each sample.  Since participants were given the option of 2 salivary sampling 
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timelines, the data needed to be collapsed into one group before statistical analysis 
could proceed.  Twenty-seven participants chose the AM/PM method, while only 7 
conducted morning rise sampling.  Since the AM sample was collected 
approximately 1 hour upon awakening, the 60 minute morning rise sample was 
determined to be the sample best temporally correspondent.  In subsequent 
analyses, only the AM and 60 minute morning rise samples were included to 
increase the power of analysis.   
The pre- and post-colonoscopy cortisol data was added to the correlation 
matrix to elucidate specific relational trends between the psychometric and 
physiological variables.  Paired samples t-tests were conducted to determine if 
significant changes in salivary cortisol concentration were observed from pre- to 
post-colonoscopy.  One sample t-tests were also conducted comparing the cortisol 
samples to the population mean of controls matched for age and gender to further 
describe any specifically observed change in cortisol concentration. 
Results 
Correlational Analysis  
Pearsons’ correlational analyses of perceived stress, depressive symptoms, 
colon cancer worry, social support and cortisol concentration yielded a couple of 
significant results across time points.  Participants’ scores on the PSS at time 1 and 
time 2 were significantly positively correlated (r (10)= .631, p< .05).  A similar 
result was found for participants’ scores on the CES-D from time 1 and time 2 (r 
(10)= .696, p< .05).  For both of these variables, the more perceived stress or 
depressive symptoms experienced prior to the procedure, the higher were the scores 
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on those measures after the procedure.  Neither Colon Cancer Worry (r (10) = .200, 
p=. 534) nor the ISEL (r (10) = .260, p= .414) demonstrated significant correlations 
across time points.  The correlation coefficient of AM cortisol concentration 
approached statistical significance across time points but did not achieve it outright 
given the small sample size (r (17)= .415, p= .097).  PM cortisol concentration did 
not demonstrate a similar result (r (9)= .417, p=. 201).   
 The subscales of the Colon Caner Worry measure, Worry and Thoughts, were 
significantly positively correlated (r (34) = .405, p< .05) prior to the colonoscopy.  
This indicates that those participants experiencing worry regarding cancer diagnosis 
were also more likely to have intrusive thoughts as well.  This finding was not 
replicated post-colonoscopy  (r (10) = .386, p= .215).  Post-colonoscopy, Colon 
Cancer Thoughts and perceived stress were significantly positively correlated (r 
(10)= .611, p< .05).  Those experiencing more perceived stress after the procedure 
were also more likely to report greater levels of intrusive colon cancer-related 
thoughts.  Interestingly, a special relationship was demonstrated between gender 
and colon cancer worry pre-colonoscopy.  Women were found to have more colon 
cancer-related worries than men (r (34) = .389, p< .05). 
Major correlational findings were discovered when examining the 
relationships of depressive symptoms, perceived stress, and AM cortisol 
concentrations prior to the colonoscopy.  It was found that perceived stress and 
depressive symptoms were positively correlated with high significance (r (34)= .635, 
p< .01).  Those participants indicating more depressive symptomatology also 
reported higher levels of perceived stress in their daily lives.  The CES-D scores were 
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also significantly correlated with AM cortisol concentration (r (34)= .348, p< .05).  
The more depressive symptoms reported at time 1, the higher levels of the stress 
hormone cortisol were found in the saliva.  See Figure 2 for the raw data 
distributions of the major output variables across time points.           
T-test analysis and Cohen’s d 
 Paired samples t-tests were conducted for the total scores on the 4 
psychometric measures and both AM and PM cortisol concentrations across time 
points.  Participants’ scores on the CES-D, PSS, ISEL-12, or Colon Cancer Worry did 
not display any significant changes in value from pre- to post-colonoscopy.  AM 
cortisol concentrations showed a highly significant decrease from time 1 to time 2 (t 
(16) = -6.443, p<. 01).  The Cohen’s d calculated for this effect was -3.327, 
indicating only a 5% overlap of mean cortisol concentrations across time points.  A 
significant result was not found for the PM saliva samples (t (10)= -1.062, p= .313).  
See Figure 3 for a graphical representation of these relationships.   
One sample t-tests were conducted separately for pre- and post-colonoscopy 
AM cortisol data to further elucidate the change in cortisol concentration with 
reference to population means for age and gender-matched controls.  For men and 
women between the ages of 51 and 70, Salimetrics, Inc., reports an AM population 
mean of 0.58mg/dl.  AM cortisol concentration pre-colonoscopy was found to be 
highly significantly increased above the population mean (t (35)=3.937, p<. 01).  The 
Cohen’s d calculated for the pre-colonoscopy data was given as d=1.37, indicating a 
large positive effect.  AM cortisol concentration post-colonoscopy was highly 
significantly decreased below the population mean (t (16)=-3.711, p<. 01).  The 
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Cohen’s d calculated for the post-colonoscopy effect was found to be d= -1.916, 
indicating a large negative effect.   
Discussion 
 While full support of the many-armed hypothesis was not achieved, the 
results of this study do solidly support many of the important claims made.  The 
psychometric measures of perceived stress and depressive symptomatology did not 
significantly change after the colonoscopy procedure as hypothesized.  However, the 
AM cortisol values decreased significantly from pre- to post-procedure.   While it 
has been shown (Roy et al., 2001; Bradley, 1988; Mrazek & Klinnert, 1996) that 
psychological stressors are often simultaneously manifested physiologically, these 
results seem to indicate that psychological stressor can elude the realm of 
perception while demonstrating its effects in the body.  Thus, it appears that though 
psychological stressors may cause changes in physiology, the element of awareness 
is not necessary.  Self-report measures highlight this possibility, as an individual 
must perceive a modicum of psychological disruption before he is able to report it on 
a questionnaire.  The results of this study seem to indicate that the colonoscopy 
appointment is a stressor that was not brought into awareness for cognitive 
processing.  This is supported by the fact that an overwhelming majority of 
participants, 91.4%, indicated that they did not fear being diagnosed with colorectal 
cancer.  Despite claiming to be unafraid of the possibility of diagnosis, the morning 
cortisol levels were significantly increased above the population mean.   
One may put forth the argument that the participants showed increases in 
cortisol concentration not because they feared diagnosis, but rather because the 
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colonoscopy procedure itself acted as a stressor.  This argument led to the inclusion 
of the one sample t-tests to further elucidate the exact nature of the changes 
occurring in morning cortisol concentration from pre- to post-colonoscopy.  If the 
colonoscopy acted merely as an acute stressor, the post-colonoscopy cortisol data 
would show a high degree of correspondence with that of the general population.  
However, when comparing the sample data to the general population, it was found 
that not only did the morning cortisol concentration decrease from pre- to post-
colonoscopy, but that it decreased to levels significantly below that of the 
population mean.  This finding shows that the change in morning cortisol 
concentration was not just due to a resolution of a stressful event.   
Further supporting this finding, Oswald et al (2004) demonstrated that 
cortisol levels elevated experimentally by an induced stressor tended to decrease 
back down to basal levels within one hour of resolution of the stressful event.  One 
may argue that while a colonoscopy is indeed a stressful event in the lives of 
patients, it is not an acute stressor.  Therefore, its effect on elevating cortisol 
concentrations may be prolonged past the 1-hour mark.  The specific procedure 
conducted during a colonoscopy yields immediate results if no polyps are found in 
the patient’s colon.  In such an instance, the patient is notified upon waking from 
anesthesia that the colon was clear of suspicious growths.  Presumably, those 
patients would not show a prolonged stress response since the event had a clearly 
defined, benign ending.  Even in patients who have polyps removed for biopsy, the 
results of such tests usually take a week to learn from the pathology lab.  At the 2-
week time point post-colonoscopy, the patients should have all been well aware of 
Cortisol and Colonoscopy  20
the outcome of their screenings.  It is understandable that those patients receiving 
colon cancer diagnosis would show a prolonged stress response in dealing with that 
information, but without access to medical records the final outcome measures of 
the individual screens cannot be commented upon.  
Correlational analyses, while insufficient to claim causality, offered some 
insight into specific relational trends of the main output variables of this study.  The 
fact that both depressive symptomatology and perceived stress were positively 
correlated with themselves across time points, further supports the idea that not all 
stressors are accessible for cognitive processing and self-report, despite the 
physiological changes that may occur with stress hormone levels.  It may be that the 
lack of availability to cognitively process the stress of the colonoscopy that leads to 
increased cortisol levels prior to the actual procedure.  Anticipatory stress most 
likely contributed to the elevated cortisol concentrations, but was unfortunately not 
assessed using the PSS given the particular retrospective timeline used in the 
measure.  The CES-D may hit on this anticipatory stress despite its retrospective 
focus, especially in the manifestations of stressful symptoms in changes in behavior, 
mood, and outlook, and issues of control.  Perhaps this is the reason why 
correlations were seen with depressive symptoms and cortisol levels, but not with 
perceived stress as assessed by the PSS.  Since the PSS and CES-D were positively 
correlated, it is evident that psychological stress is strongly related to negative 
changes in affect.  It stands to reason that while the participants may have been 
unaware of the entirety of their psychological stress, as evidenced by the cortisol 
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data, they did notice changes in mood that represented the true magnitude of their 
stress.   
Finally, only one major psychometric output demonstrated any specific 
relationship with gender.  Women, who made up approximately 50% of the sample 
at either time point, reported a significantly greater amount of colon cancer-related 
worry than men.  This phenomenon may be due to increased perceptions of concern 
for familial ties that may be negatively affected by a potential cancer diagnosis.  
Women tend to put the feelings and needs of others and ahead of their own, which 
may lead to more intrusive thoughts and worries about the possibility of colon 
cancer diagnosis.  Also, women are more likely than men to use introspection to 
examine their thoughts, and more emotionally expressive in stressful situations 
(Fernandez-Ballesteros et al., 1998).  This may feed the correlation of women 
seemingly experiencing more cancer-related worry than men.  While this may be 
true, it also may be that women are just more adept at pinpointing the source of 
their stress and expressing it to others.   
Implications 
The colonoscopy not only provided the health benefits associated with cancer 
screening but also led to a decrease in cortisol concentration below that of the 
population mean.  This is an important finding, since short term high cortisol has 
been implicated in abdominal weight gain, elevated blood glucose leading to insulin 
resistance, high blood pressure, osteoporosis, easy bruising, and disorders of the 
immune system (Roberts et al., 2007; Kertzner et al., 1993).  Chronically, elevated 
cortisol is very dangerous to physical health.  It can cause hormonal imbalances, 
Cortisol and Colonoscopy  22
short-term memory loss, and contribute to Alzheimer’s disease and senile dementia 
(Peavy et al., 2007).   And while low cortisol levels are also maladaptive, the 
decrease from population mean observed in this sample would not qualify as 
pathologically low cortisol.  In this sample, the lowered cortisol levels allow for 
quicker recovery from stress and decrease the potential risk factors of other health 
problems.  This may encourage some of the 41.8 million Americans not following the 
proper screening timeline advocated by the Center for Disease Control to receive a 
colonoscopy once every decade.  This study may educate the general public about 
the benefits of a colonoscopy, and contribute to greater awareness of colon cancer 
and its risk factors.  From a health psychology standpoint, the findings of this study 
could encourage people to adopt potentially life-saving health behaviors, and 
contribute to the overall health and wellness of the population.        
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Appendix 
 
Colon Cancer Worry Scale- unpublished measure created by Dean Cruess, Ph. D. at 
the University of Connecticut to assess colon cancer-specific patterns of thoughts 
and worries.   
 
1 = Not at all or rarely 
2 = Sometimes 
3 = Often 
4 = A lot 
 
_________During the past month, how often have you thought about your own 
chances of getting colorectal cancer? 
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_________During the past month, how often have your thoughts about getting 
colorectal cancer affected your mood? 
 
_________During the past month, how often have your thoughts about getting 
colorectal cancer affected your ability to perform your daily activities? 
 
_________During the past month, how often have you worried about getting 
colorectal cancer? 
 
 
1 = Strongly disagree 
2 = Disagree 
3 = Agree 
4 = Strongly Agree 
 
________ I worry that I already have colorectal cancer. 
 
________ I fear being diagnosed with colorectal cancer.  
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Figure Captions 
Figure 1.  Participants were instructed to complete the 10-minute questionnaire 2 
weeks before and after their scheduled colonoscopy appointment.  Optional saliva 
sampling was also conducted at each time point using either AM/PM or morning rise 
sample schedules.    
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Figure 2.  Scatter plots of pre- and post-colonoscopy data were created to 
demonstrate correlations within variables across time points.  Both depressive 
symptoms (CES-D) and perceived stress (PSS) were positively correlated with one 
another.   AM cortisol concentration was not significantly correlated across time 
points.  Note the similarity in the shape of the distributions of the CES-D and AM 
cortisol concentration.  This indicates that the CES-D may have been a better 
indicator of stress levels than the PSS.  
 
 
Figure 3. T-test analyses conducted on the mean cortisol concentrations across time 
points yielded significant results only for the morning samples.  AM cortisol 
concentration was found to be highly significantly decreased from pre- to post-
colonoscopy (t (16) = -6.443, p<. 01).  Double asterisks (**) indicate highly 
significant differences.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Timeline of experimental procedure followed by participants 
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Figure 2.  Raw data distributions of depressive symptoms, perceived stress, and 
cortisol concentration across time points 
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Figure 3.  Comparison of mean AM and PM cortisol concentrations across time 
points  
 
 
 
